JARDY MET 12.5/500MG TAB NEW

JARDY MET is a combination tablet containing Empagliflozin 12.5mg and Metformin HCl 500mg. This dual-action medication is designed to help manage type 2 diabetes by improving blood sugar control through two complementary mechanisms. Empagliflozin works by increasing glucose excretion through urine, while Metformin reduces glucose production in the liver and improves insulin sensitivity. Suitable for adults whose diabetes cannot be adequately controlled with diet and exercise alone. Each tablet combines proven efficacy with convenient once or twice-daily dosing. Consult your healthcare provider to determine if JARDY MET is appropriate for your treatment plan.